Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-187149
Filing Date
2026-04-28
Accepted
2026-04-28 16:19:48
Documents
19
Period of Report
2026-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A whwk-20260428.htm   iXBRL DEF 14A 1216806
2 GRAPHIC img96983719_0.jpg GRAPHIC 19598
3 GRAPHIC img96983719_1.jpg GRAPHIC 19598
4 GRAPHIC img96983719_2.jpg GRAPHIC 19598
5 GRAPHIC img96983719_3.jpg GRAPHIC 320093
6 GRAPHIC img96983719_4.jpg GRAPHIC 326209
7 GRAPHIC img96983719_5.jpg GRAPHIC 2503780
8 GRAPHIC img96983719_6.jpg GRAPHIC 1826392
  Complete submission text file 0001193125-26-187149.txt   13470174

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT whwk-20260428.xsd EX-101.SCH 14767
22 EXTRACTED XBRL INSTANCE DOCUMENT whwk-20260428_htm.xml XML 317398
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38560 | Film No.: 26908150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)